While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies — as Jeff Bezos said, “Your margin is my opportunity”.
A business making money today isn’t necessarily a winner, which is why we analyze companies across multiple dimensions at StockStory. That said, here is one profitable company that generates reliable profits without sacrificing growth and two that may face some trouble.
Two Stocks to Sell:
H&R Block (HRB)
Trailing 12-Month GAAP Operating Margin: 23.1%
Founded in 1955 by brothers Henry W. Bloch and Richard A. Bloch, H&R Block (NYSE: HRB) is a tax preparation company offering professional tax assistance and financial solutions to individuals and small businesses.
Why Should You Dump HRB?
- Sales tumbled by 2.1% annually over the last five years, showing consumer trends are working against it
- Earnings growth underperformed the sector average over the last five years as its EPS grew by just 8.8% annually
- Diminishing returns on capital suggest its earlier profit pools are drying up
H&R Block’s stock price of $37.39 implies a valuation ratio of 1.2x forward price-to-sales. Read our free research report to see why you should think twice about including HRB in your portfolio.
FactSet (FDS)
Trailing 12-Month GAAP Operating Margin: 31.2%
Founded in 1978 when financial data was still primarily delivered through paper reports, FactSet (NYSE: FDS) provides financial data, analytics, and technology solutions that investment professionals use to research, analyze, and manage their portfolios.
Why Does FDS Give Us Pause?
- Muted 5.6% annual revenue growth over the last two years shows its demand lagged behind its financials peers
- Earnings growth over the last two years fell short of the peer group average as its EPS only increased by 7.1% annually
FactSet is trading at $246.39 per share, or 13.8x forward P/E. To fully understand why you should be careful with FDS, check out our full research report (it’s free).
One Stock to Buy:
Mirion (MIR)
Trailing 12-Month GAAP Operating Margin: 6.3%
With its technology protecting workers in over 130 countries and equipment used in 80% of cancer centers worldwide, Mirion Technologies (NYSE: MIR) provides radiation detection, measurement, and monitoring solutions for medical, nuclear energy, defense, and scientific research applications.
Why Are We Backing MIR?
- Market share has increased this cycle as its 10.8% annual revenue growth over the last five years was exceptional
- Adjusted operating profits increased over the last five years as the company gained some leverage on its fixed costs and became more efficient
- Free cash flow margin jumped by 8.7 percentage points over the last five years, giving the company more resources to pursue growth initiatives, repurchase shares, or pay dividends
At $17.38 per share, Mirion trades at 4.3x trailing 12-month price-to-sales. Is now the right time to buy? See for yourself in our in-depth research report, it’s free.
Stocks We Like Even More
ONE MORE THING: Top 5 Growth Stocks. The biggest stock winners almost always had one thing in common before they ran. Revenue growing like crazy. Meta. CrowdStrike. Broadcom. Our AI flagged all three. They returned 315%, 314%, and 455%, respectively.
Find out which 5 stocks it’s flagging this month — FREE. Get Our Top 5 Growth Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.
